CAMPSIITE RGX-121

· REGENXBIO Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAMPSIITE RGX-121, covering 2025-01-28 to 2025-01-28. Get the full timeline:

Most recent: Clinical Trial Update: CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome) [Phase 2, Phase 3]